Original Source(s)
Related Content
FDA Approves Auvelity for Agitation in Alzheimer’s Disease
The oral combination therapy expands treatment options for agitation associated with dementia due to Alzheimer’s disease.
April 30, 2026
-
3 min
Retinal Imaging AI May Flag Brain Health Risk
Authors said AI-driven retinal screening still lacks evidence that it improves patient outcomes.
by Kerri Miller
May 29, 2026
-
3 min
Stroke Severity Linked to Dementia Risk
Findings support greater attention to stroke prevention and poststroke cognitive monitoring.
June 5, 2026
-
6 min